Gastrointestinal Therapeutics Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Gastrointestinal Therapeutics Market: By Drug Glass (Antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents and Others), Mode of Administration (Oral, Intravenous and Others), Application (Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer Disease),  Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Gastrointestinal Therapeutics Market size is valued at USD 52.8 billion in 2021 and is expected to grow at a CAGR of 6.9% forecast period 2022 to 2028. The global market provides a detailed overview of the Gastrointestinal Therapeutics market, and that can be segmented by drug, by mode of administration, by application, and by Distribution channel. By drug, the Gastrointestinal Therapeutics market has been segmented into antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, and Others. The Laxatives segment is likely to be the significant growing segment in drugs. Based on the Mode of administration, the Gastrointestinal Therapeutics market is segmented into Oral, Intravenous, and Others. Among these, the Intravenous segment is expected to have the fastest-growing market during the forecast period 2022-2028. The considerable share is expected to be an outcome of the advantages related to IV products. It can also be due to the high price of IV products compared to oral care products. Based on the application, the Gastrointestinal Therapeutics market is segmented into Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer. The Gastroenteritis Gastrointestinal Bleeding segment is expected to have a significant share in 2021. The rise of this segment is mainly because it offers an extensive range of applications for which gastrointestinal medicines have been used steadily over the prior years. Recurrent drug launches is also accountable for increased scope for development. Based on the Distribution channel, the Gastrointestinal Therapeutics market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The Retail Pharmacies segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the convenience and high affordability of retail stores. As the number of prescription drugs being compensated grows, it inspires patients to buy medicines from retail pharmacies. Retail pharmacists also endorse drug alternatives that avoid severe drug interactions.

Key Developments:

In February 2021, in the United States, Lansoprazole delayed-release orally disintegrating tablets were launched by Dr. Reddy’s Laboratories.

In March 2020, Sebela Pharmaceuticals got approval from FDA for Pizensy (lactitol) for curing chronic idiopathic constipation (CIC) in adults.

Gastrointestinal Therapeutics Market

MARKET SUMMARY
-
6.9% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR–6.9%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Gastrointestinal Therapeutics Market

  • The gastrointestinal therapeutics market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The gastrointestinal therapeutics market is segmented based on drug, mode of administration, application, distribution channel and geography.
Key Players
  • Abbott Laboratories (US)
  • Allergan (Ireland)
  • AstraZeneca plc (UK)
  • GlaxoSmithKline Plc (UK)
  • Takeda Pharmaceutical Company Limited (Japan)
Gastrointestinal Therapeutics Market Drivers

The growing incidence of gastrointestinal diseases is anticipated to propel the market growth over the forecast years. Moreover, the increasing clinical trials with promising results and increasing expenditure on healthcare are burgeoning the market growth over the forecast years.


North-America got significant share

Gastrointestinal Therapeutics Market

North America market is expected to witness the highest market share during the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Gastrointestinal Therapeutics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The gastrointestinal therapeutics market is projected to expand at a CAGR of 6.9% during the forecast period

Abbott Laboratories (US), Allergan (Ireland), AstraZeneca plc (UK), GlaxoSmithKline Plc (UK), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (US), Bayer AG (Germany), Bausch Health (Canada), Merck & Co., Inc. (US), AbbVie Inc. (US)

North America is the fastest-growing region for gastrointestinal therapeutics market


Report

Table Of Content

  1. Executive Summary
  2. Global Gastrointestinal Therapeutics Market Introduction
    • Global Gastrointestinal Therapeutics Market – Taxonomy
    • Global Gastrointestinal Therapeutics Market –Definitions
      • By Drug Type
      • By Product
      • By Route of Administration
      • By Application
      • By Distribution Channel
      • By Region
  1. Global Gastrointestinal Therapeutics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Gastrointestinal Therapeutics Market Dynamic Factors – Impact Analysis
    • Global Gastrointestinal Therapeutics Market – Competition Landscape
  2. Global Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Gastrointestinal Therapeutics Market, By Drug Type, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Antacids
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laxatives
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antidiarrheal agents
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antiemetics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Antiulcer agents
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Product Type, 2014 – 2018 and Forecast, 2019 – 2025
    • Prescription based therapeutics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • OTC therapeutics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Product, Route of Administration, 2014 – 2018 and Forecast, 2019 – 2025
    • Oral
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Intravenous
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market, By Application, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Ulcerative Colitis
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Crohn’s Disease
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • GERD
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Irritable Bowel Syndrome
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptic Ulcer Disease (PUD)
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Distribution Channel, 2014 – 2018 and Forecast, 2019 – 2025
    • Hospital Pharmacies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Gastrointestinal Therapeutics Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Region, 2019 – 2025
  2. North America Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • North America Gastrointestinal Therapeutics Market Dynamics – Trends
  3. Europe Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • Europe Gastrointestinal Therapeutics Market Dynamics – Trends
  4. Asia-Pacific Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • Asia-Pacific Gastrointestinal Therapeutics Market Dynamics – Trends
  5. Latin America Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • Latin America Gastrointestinal Therapeutics Market Dynamics – Trends
  6. Middle East and Africa Gastrointestinal Therapeutics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • By Drug Type, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Antacids
      • laxatives
      • Antidiarrheal agents
      • Antiemetics
      • Antiulcer agents
      • Others
    • By Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription based therapeutics
      • OTC therapeutics
    • By Route of Administration Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Intravenous
      • Others
    • By Application, 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Ulcerative Colitis
      • Crohn’s Disease
      • GERD
      • Irritable Bowel Syndrome
      • Peptic Ulcer Disease (PUD)
      • Others
    • By Distribution Channel Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Gastrointestinal Therapeutics Market – Opportunity Analysis Index, By Drug Type, Product, Route of Administration, Application, Distribution Channel, and Country, 2019 – 2025
    • MEA Gastrointestinal Therapeutics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Abbott Laboratories (US)
      • Allergan (Ireland)
      • AstraZeneca plc (UK)
      • GlaxoSmithKline Plc (uk)
      • Takeda Pharmaceutical Company Limited (Japan)
      • Pfizer Inc (US)
      • Bayer AG (Germany)
      • Bausch Health (Canada)
      • Merck & Co., Inc. (US)
      • AbbVie Inc. (US)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Abbott Laboratories (US)
  • Allergan (Ireland)
  • AstraZeneca plc (UK)
  • GlaxoSmithKline Plc (UK)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Pfizer Inc. (US)
  • Bayer AG (Germany)
  • Bausch Health (Canada)
  • Merck & Co., Inc. (US)
  • AbbVie Inc. (US)

Description

Gastrointestinal Therapeutics Market size is valued at USD 52.8 billion in 2021 and is expected to grow at a CAGR of 6.9% forecast period 2022 to 2028. The global market provides a detailed overview of the Gastrointestinal Therapeutics market, and that can be segmented by drug, by mode of administration, by application, and by Distribution channel. By drug, the Gastrointestinal Therapeutics market has been segmented into antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, and Others. The Laxatives segment is likely to be the significant growing segment in drugs. Based on the Mode of administration, the Gastrointestinal Therapeutics market is segmented into Oral, Intravenous, and Others. Among these, the Intravenous segment is expected to have the fastest-growing market during the forecast period 2022-2028. The considerable share is expected to be an outcome of the advantages related to IV products. It can also be due to the high price of IV products compared to oral care products. Based on the application, the Gastrointestinal Therapeutics market is segmented into Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer. The Gastroenteritis Gastrointestinal Bleeding segment is expected to have a significant share in 2021. The rise of this segment is mainly because it offers an extensive range of applications for which gastrointestinal medicines have been used steadily over the prior years. Recurrent drug launches is also accountable for increased scope for development. Based on the Distribution channel, the Gastrointestinal Therapeutics market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The Retail Pharmacies segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the convenience and high affordability of retail stores. As the number of prescription drugs being compensated grows, it inspires patients to buy medicines from retail pharmacies. Retail pharmacists also endorse drug alternatives that avoid severe drug interactions.

Key Developments:

In February 2021, in the United States, Lansoprazole delayed-release orally disintegrating tablets were launched by Dr. Reddy’s Laboratories.

In March 2020, Sebela Pharmaceuticals got approval from FDA for Pizensy (lactitol) for curing chronic idiopathic constipation (CIC) in adults.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX